Rising Hair Loss Cases Drive Growth In The Androgenetic Alopecia Treatment Market: The Driving Engine Behind Androgenetic Alopecia Treatment Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Androgenetic Alopecia Treatment Market Size Growth Forecast: What to Expect by 2025?
The market for treating androgenetic alopecia has seen significant growth in recent times. It's projected to increase from a value of $2.29 billion in 2024 to about $2.44 billion in 2025, following a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the historic period include a focus on enhancing patient results and quality of life, a rise in the elderly population, and an upswing in healthcare spending.

How Will the Androgenetic Alopecia Treatment Market Size Evolve and Grow by 2029?
A robust expansion of the androgenetic alopecia treatment market is expected in the upcoming years, with projections suggesting it will reach a valuation of $3.19 billion by 2029. This growth, at a compound annual growth rate (CAGR) of 6.9%, is attributed to an increase in instances of hair loss, the widespread incidence of chronic illnesses like cancer, polycystic ovary* syndrome (PCOS), and rheumatoid arthritis, and the demand for effective remedies to tackle hair loss issues. Noteworthy trends predicted for this period include alliances, approval of products, investments, and advancements in research and development.

View the full report here:
https://www.thebusinessresearchcompany.com/report/androgenetic-alopecia-treatment-global-market-report

What Drivers Are Propelling the Growth of Androgenetic Alopecia Treatment Market Forward?
The increasing incidence of hair loss is anticipated to drive the expansion of the androgenetic alopecia treatment market. Alopecia, also known as hair loss, is defined as the total or partial loss of hair from the scalp or other areas of the body. Hair loss is associated with factors like nutritional deficiencies, hormonal imbalances, genetic factors and heightened stress levels. Treatments for Androgenetic alopecia function through several methods, such as hormonal regulation, follicle stimulation, and surgical restoration to address hair loss and encourage regrowth. For example, a US-based professional organisation, the Hair Society, published an article in March 2022 suggesting that hair loss has impacted around 21 million women and 35 million men worldwide. Furthermore, according to the National Health Service, a government agency in the UK, an estimated 8 million women and 6.5 million men in the UK suffer from hair loss as of 2024. Additionally, over 650,000 hair transplant processes are performed annually. Hence, the surge in the cases of hair loss fuels the growth of the androgenetic alopecia treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15721&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Androgenetic Alopecia Treatment Market?
Leading businesses in the androgenetic alopecia therapy industry are advancing new drug methods to combat hair loss using approaches such as promoting hair follicle rejuvenation, restricting hormones linked to hair loss, and incorporating innovative delivery techniques like topical applications and oral drugs. For example, Pfizer Inc., an American healthcare firm, obtained FDA approval in June 2023 for LITFULO (ritlecitinib), a daily oral therapy for individuals 12 years old and above with severe alopecia areata. LITFULO, a kinase inhibitor, acts by suppressing Janus kinase 3 (JAK3) and the tyrosine kinase found in the TEC family of kinases. The ALLEGRO Phase 2b/3 trial, which resulted in 23% of patients attaining 80% or more scalp hair coverage after half a year compared to 1.6% with a placebo, led to the FDA approval. LITFULO provides a novel alternative for people dealing with major hair loss, answering a previously unsatisfied demand for alopecia areata treatments.

What Are the Key Segments in the Androgenetic Alopecia Treatment Market?
The androgenetic alopecia treatment market covered in this report is segmented -

1) By Treatment Type: Pharmaceutical, Device
2) By Medication Type: Prescription, Over-The-Counter
3) By Gender: Male, Female
4) By End-User: Homecare Settings, Dermatology, Clinics, Other End-Users

Subsegments:
1) By Pharmaceutical: Oral Medications ( Finasteride), Topical Medications (Minoxidil), Hormonal Therapy
2) By Device: Laser Therapy Devices, Hair Transplant Devices, Scalp Micropigmentation Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15721&type=smp

Who Are the Key Players Shaping the Androgenetic Alopecia Treatment Market's Competitive Landscape?
Major companies operating in the androgenetic alopecia treatment market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company, Daiichi-Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Allergan Plc, Aurobindo Pharma Limited, Dr Reddy's Laboratories Ltd., Cipla Limited, Fagron Inc., Vitabiotics Ltd., Cosmo Pharmaceuticals NV, Aclaris Therapeutics Inc., Curallux LLC, PureTech Health, Technoderma Medicines Inc., Theradome Inc., Lexington International, HCell Inc., Follica Inc., Ranbaxy Laboratories Ltd., Apira Science Inc., Freedom Laser Therapy Inc., Histogen Inc.

What Geographic Markets Are Powering Growth in the Androgenetic Alopecia Treatment Market?
North America was the largest region in the androgenetic alopecia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgenetic alopecia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15721

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.